Form D · Pharmaceuticals
CorMedix Inc.
Bridgewater, NJ · CIK 0001410098
Offering snapshot reported Oct 3, 2012 · SEC filing
- Reported sold
- $850K Offering amount: $3M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Sep 11, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 3, 2012 | Initial | $850,000 | No comparison | 8 | SEC filing |
| Nov 13, 2009 | Initial | $2,619,973 | No comparison | 19 | SEC filing |
| Sep 2, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $300K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-184955
Total Offering Amount excludes over-subscription option of up to $800,000.
Assumes sale of total offering amount, but excludes any over-subscription and warrants issuable to the placement agent
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| John Carris Investments, LLC | 145767 |
Source: Form D, filed Oct 3, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard M. Cohen | Director, Executive |
| Bruce Cooper | Director |
| Matthew Duffy | Director |
| Russell Ellison | Director |
| Gary A. Gelbfish | Director |
| Timothy Hofer | Director |
| John Houghton | Director, Executive |
| Mark Houser | Executive |
| Steven W. Lefkowitz | Director |
| Randy Milby | Executive |
| Mahendra Patel | Director |
| Anthony E. Pfaffle | Director |
| Antony Pfaffle | Director |
| Stephen Pilatzke | Executive |
| Lindsay Rosenwald | Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
745 Route 202 206 Suite 303
Bridgewater, NJ, 08807
Bridgewater, NJ, 08807